4850KRW
28.43 BKRW
195.91 BKRW
3.40 M
About DAIHANPHARM
Sector
Industry
CEO
Yoon-Woo Lee
Website
Headquarters
Seoul
Employees (FY)
708
Founded
1945
ISIN
KR7023910003
FIGI
BBG000C1MB31
Daihan Pharmaceutical Co., Ltd. engages in the manufacture and sale of medical products. The company operates through Pharmaceutical products and Other. Its main products include sap ample and contract research services. The company was founded by In-Sil Lee in 1945 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 023910 is 28100.00 KRW — it has increased by 0.54% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange DAIHANPHARM stocks are traded under the ticker 023910.
DAIHANPHARM revenue for the last quarter amounts to 48.70 B KRW despite the estimated figure of 49.70 B KRW. In the next quarter revenue is expected to reach 51.50 B KRW.
Yes, you can track DAIHANPHARM financials in yearly and quarterly reports right on TradingView.
023910 stock has risen by 0.72% compared to the previous week, the month change is a 0.18% fall, over the last year there was no change in DAIHANPHARM price.
Like other stocks, 023910 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DAIHANPHARM stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 708.00 employees. See our rating of the largest employees — is DAIHANPHARM on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DAIHANPHARM EBITDA is 44.45 B KRW, and current EBITDA margin is 22.69%. See more stats in DAIHANPHARM financial statements.